Hypertrophic Cardiomyopathy: Experience in Pakistan
DOI:
https://doi.org/10.47144/phj.v13i2.494Keywords:
Hypertrophic Cardiomyopathy, Experience in PakistanAbstract
Material and Methods:
Between Jan’79 and July’80, a total of 460 Echoes were performed, out of which 13 patients were diagnosed to have HCM. Clinical history and a complete physical was obtained in all patients.
Discussion:
It may seem odd that despite the tremendous interest HCM generated in the Cardiology circles all over the world, the disease was not described from Pakistan until 1978(3). The reason for this may have been partly a lack of awareness about this disease entity locally. The dose of propranolol could not be increased beyond 120 mg daily due to concomitant presence of sick sinus syndrome and occurrence of severe sinus bradycardia. This patient was started on oral verapamil and has responded very well to it. No problem with sinus bradyemdia has so far been noted on verapamil (12).
Downloads
Downloads
How to Cite
Issue
Section
License
When an article is accepted for publication in the print format, the author will be required to transfer exclusive copyright to the PHJ and retain the rights to use and share their published article with others. However, re-submission of the full article or any part for publication by a third party would require prior permission of the PHJ.
Online publication will allow the author to retain the copyright and share the article under the agreement described in the licensing rights with creative commons, with appropriate attribution to PHJ. Creative Commons attribution license CC BY 4.0 is applied to articles published in PHJ https://creativecommons.org/licenses/by/4.0/
